Medical Financial Statements From 2010 to 2025
| MDDVF Stock | USD 0.30 0.01 3.23% |
Check Medical Developments financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Medical Developments' main balance sheet or income statement drivers, such as , as well as many indicators such as . Medical financial statements analysis is a perfect complement when working with Medical Developments Valuation or Volatility modules.
Medical |
Medical Developments International Company Return On Asset Analysis
Medical Developments' Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Medical Developments Return On Asset | -0.0787 |
Most of Medical Developments' fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medical Developments International is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Medical Developments International has a Return On Asset of -0.0787. This is 99.1% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The return on asset for all United States stocks is 43.79% lower than that of the firm.
Medical Developments Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Medical Developments's current stock value. Our valuation model uses many indicators to compare Medical Developments value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Medical Developments competition to find correlations between indicators driving Medical Developments's intrinsic value. More Info.Medical Developments International is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Medical Developments' earnings, one of the primary drivers of an investment's value.About Medical Developments Financial Statements
Medical Developments stakeholders use historical fundamental indicators, such as Medical Developments' revenue or net income, to determine how well the company is positioned to perform in the future. Although Medical Developments investors may analyze each financial statement separately, they are all interrelated. For example, changes in Medical Developments' assets and liabilities are reflected in the revenues and expenses on Medical Developments' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Medical Developments International. Please read more on our technical analysis and fundamental analysis pages.
Medical Developments International Limited manufactures and distributes pharmaceutical and veterinary products, and medical devices. The company was incorporated in 2003 and is headquartered in Scoresby, Australia. Medical Developments operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 68 people.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in Medical Pink Sheet
Medical Developments financial ratios help investors to determine whether Medical Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medical with respect to the benefits of owning Medical Developments security.